Chemoinformaics analysis of Isorauhimbinic acid
| Molecular Weight | 340.423 | nRot | 1 |
| Heavy Atom Molecular Weight | 316.231 | nRig | 26 |
| Exact Molecular Weight | 340.179 | nRing | 5 |
| Solubility: LogS | -2.752 | nHRing | 3 |
| Solubility: LogP | 1.698 | No. of Aliphatic Rings | 3 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 10 |
| nHA | 3 | APOL | 54.009 |
| nHD | 3 | BPOL | 27.225 |
| QED | 0.746 |
| Synth | 3.863 |
| Natural Product Likeliness | 1.149 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.973 |
| HIA | 0.039 |
| CACO-2 | -5.744 |
| MDCK | 0.00000612 |
| BBB | 0.703 |
| PPB | 0.776636 |
| VDSS | 1.864 |
| FU | 0.250679 |
| CYP1A2-inh | 0.114 |
| CYP1A2-sub | 0.718 |
| CYP2c19-inh | 0.03 |
| CYP2c19-sub | 0.675 |
| CYP2c9-inh | 0.02 |
| CYP2c9-sub | 0.49 |
| CYP2d6-inh | 0.024 |
| CYP2d6-sub | 0.785 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.269 |
| CL | 6.297 |
| T12 | 0.817 |
| hERG | 0.136 |
| Ames | 0.008 |
| ROA | 0.533 |
| SkinSen | 0.43 |
| Carcinogencity | 0.568 |
| EI | 0.073 |
| Respiratory | 0.973 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.556271 |